JSF Financial LLC Reduces Position in Cardinal Health, Inc. $CAH

JSF Financial LLC decreased its holdings in Cardinal Health, Inc. (NYSE:CAH) by 30.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 6,612 shares of the company’s stock after selling 2,838 shares during the period. JSF Financial LLC’s holdings in Cardinal Health were worth $1,397,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of the stock. Aventura Private Wealth LLC purchased a new stake in shares of Cardinal Health in the fourth quarter valued at about $25,000. University of Texas Texas AM Investment Management Co. purchased a new position in Cardinal Health during the fourth quarter worth about $26,000. Bank of Jackson Hole Trust acquired a new position in Cardinal Health in the 4th quarter valued at about $27,000. Jones Financial Companies Lllp boosted its holdings in Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares during the last quarter. Finally, Palladiem LLC purchased a new stake in shares of Cardinal Health in the 4th quarter valued at approximately $28,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Wall Street Analyst Weigh In

CAH has been the topic of several analyst reports. Zacks Research lowered shares of Cardinal Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, June 12th. Morgan Stanley increased their price objective on Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 28th. JPMorgan Chase & Co. reduced their target price on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a research report on Monday, May 4th. Citigroup reaffirmed a “buy” rating on shares of Cardinal Health in a research note on Thursday, July 2nd. Finally, Weiss Ratings cut Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a report on Tuesday, May 19th. Fifteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $250.07.

Cardinal Health Stock Performance

Shares of CAH stock opened at $225.76 on Tuesday. The firm has a market cap of $52.88 billion, a P/E ratio of 34.52, a P/E/G ratio of 1.12 and a beta of 0.49. The firm’s 50 day moving average price is $217.11 and its 200-day moving average price is $213.94. Cardinal Health, Inc. has a one year low of $137.75 and a one year high of $243.21.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The company had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. During the same quarter in the previous year, the company earned $2.35 earnings per share. The firm’s quarterly revenue was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, research analysts predict that Cardinal Health, Inc. will post 10.77 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st were issued a $0.5158 dividend. The ex-dividend date was Wednesday, July 1st. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio (DPR) is presently 31.50%.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.